Jennie Welch
Family · Fort Eisenhower, GANPI 1962962209
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,247 and has fallen 89.0% since, to $137 in 2025.
Across 158 payments — averaging $23.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$663
- GSK$455
- Johnson & Johnson$278
- Bayer$264
- Lilly USA, LLC$231
- AbbVie$215
- plus $2K from 21 others
What the payments were for
- Food & beverage$3,708100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 29 | $663 |
| GSK | 16 | $455 |
| Johnson & Johnson | 8 | $278 |
| Bayer | 14 | $264 |
| Lilly USA, LLC | 15 | $231 |
| AbbVie | 5 | $215 |
| AstraZeneca | 13 | $194 |
| Amgen | 4 | $162 |
| Pharmacosmos Therapeutics Inc. | 1 | $149 |
| Otsuka America Pharmaceutical, Inc. | 1 | $137 |
| Amarin Pharma, Inc. | 7 | $128 |
| Pfizer | 7 | $114 |
| Viiv Healthcare Company | 1 | $109 |
| Sunovion Pharmaceuticals Inc. | 4 | $82 |
| Biogen | 4 | $80 |
| Boehringer Ingelheim | 5 | $76 |
| Novartis | 5 | $71 |
| Merck | 3 | $51 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Astellas Pharma US Inc | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $39 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Shield Therapeutics Inc | 1 | $16 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,708 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 11 | $85 |
| Amlodipine Besylate | 12 | $67 |
Paid to pharmacies, not to this prescriber.
Other family in Fort Eisenhower
- Allie McAllisterMarietta$299K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
- Julia ThorneCanton$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.